Decoding Neurology.
In the blink of AI.

Ocular biomarker AI engine

We develop proprietary ocular biomarkers to revolutionise neurology care and drug development. Our collaborations with world-leading clinical and research organisations1 enable us to create state-of-the-art digital biomarker capture and analytics products.

[1]: University of Oxford, University College London Hospitals, Guy's and St Thomas' Hospital, Queen Mary University

Get early access to our technology.

Request a demo
Patients Clinics Pharma

Frontier of neurological care

Solvemed works with patients, healthcare providers and life sciences industry to establish the next level of care for people suffering from neurodegenerative disorders.

LinkedIn News